[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f0xQ1iPWRmyGqH-oob97fiy4kMgiqAnNUe1ZDGvA1qXA":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":8,"nonDrugCount":11,"topConditions":12,"upcomingReadouts":33,"phaseBuckets":34,"rows":41},"Shriners Hospitals for Children",[4],56,false,0,4,5274,45,[13,16,19,21,24,27,29,31],{"name":14,"count":15},"Burns",10,{"name":17,"count":18},"Cerebral Palsy",8,{"name":20,"count":9},"Scoliosis",{"name":22,"count":23},"Neurofibromatosis Type 1",3,{"name":25,"count":26},"Spinal Cord Injury",2,{"name":28,"count":26},"Sleep",{"name":30,"count":26},"Gait",{"name":32,"count":26},"Clubfoot",[],[35,36,37,38,39,40],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[42,70,88,114,132,156,174,201,226,250,268,291,317,354],{"intervention":43,"totalTrials":44,"cells":45},"Methylnaltrexone",1,{"EARLY_PHASE1":46,"PHASE1":48,"PHASE2":50,"PHASE3":52,"PHASE4":54,"NA":68},{"trials":47,"activeCount":8},[],{"trials":49,"activeCount":8},[],{"trials":51,"activeCount":8},[],{"trials":53,"activeCount":8},[],{"trials":55,"activeCount":8},[56],{"nctId":57,"briefTitle":58,"status":59,"phases":60,"primaryCompletion":61,"completion":61,"start":62,"enrollment":63,"conditions":64,"interventions":66},"NCT01773096","Methylnaltrexone Use for Opioid-induced Postoperative Constipation","COMPLETED",[39],"2015-05","2013-05",60,[65],"Constipation",[43,67],"Senna, docusate sodium, bisacodyl, magnesium hydroxide, Miralax",{"trials":69,"activeCount":8},[],{"intervention":67,"totalTrials":44,"cells":71},{"EARLY_PHASE1":72,"PHASE1":74,"PHASE2":76,"PHASE3":78,"PHASE4":80,"NA":86},{"trials":73,"activeCount":8},[],{"trials":75,"activeCount":8},[],{"trials":77,"activeCount":8},[],{"trials":79,"activeCount":8},[],{"trials":81,"activeCount":8},[82],{"nctId":57,"briefTitle":58,"status":59,"phases":83,"primaryCompletion":61,"completion":61,"start":62,"enrollment":63,"conditions":84,"interventions":85},[39],[65],[43,67],{"trials":87,"activeCount":8},[],{"intervention":89,"totalTrials":44,"cells":90},"Selenium1",{"EARLY_PHASE1":91,"PHASE1":93,"PHASE2":95,"PHASE3":97,"PHASE4":99,"NA":112},{"trials":92,"activeCount":8},[],{"trials":94,"activeCount":8},[],{"trials":96,"activeCount":8},[],{"trials":98,"activeCount":8},[],{"trials":100,"activeCount":8},[101],{"nctId":102,"briefTitle":103,"status":104,"phases":105,"primaryCompletion":106,"completion":106,"start":107,"enrollment":108,"conditions":109,"interventions":110},"NCT00860379","The Effect of Selenium Supplementation Among Pediatric Patients With Burns","TERMINATED",[39],"2019-12","2009-01",14,[14],[89,111],"Selenium2",{"trials":113,"activeCount":8},[],{"intervention":111,"totalTrials":44,"cells":115},{"EARLY_PHASE1":116,"PHASE1":118,"PHASE2":120,"PHASE3":122,"PHASE4":124,"NA":130},{"trials":117,"activeCount":8},[],{"trials":119,"activeCount":8},[],{"trials":121,"activeCount":8},[],{"trials":123,"activeCount":8},[],{"trials":125,"activeCount":8},[126],{"nctId":102,"briefTitle":103,"status":104,"phases":127,"primaryCompletion":106,"completion":106,"start":107,"enrollment":108,"conditions":128,"interventions":129},[39],[14],[89,111],{"trials":131,"activeCount":8},[],{"intervention":133,"totalTrials":44,"cells":134},"Bupivacaine",{"EARLY_PHASE1":135,"PHASE1":137,"PHASE2":139,"PHASE3":141,"PHASE4":143,"NA":154},{"trials":136,"activeCount":8},[],{"trials":138,"activeCount":8},[],{"trials":140,"activeCount":8},[],{"trials":142,"activeCount":8},[],{"trials":144,"activeCount":8},[145],{"nctId":146,"briefTitle":147,"status":59,"phases":148,"primaryCompletion":149,"completion":149,"start":150,"enrollment":63,"conditions":151,"interventions":152},"NCT00508066","Continuous Local Infusion of Anesthetic at the Incisional Site for Scoliosis Surgery",[39],"2011-01","2007-05",[20],[133,153],"Normal Saline",{"trials":155,"activeCount":8},[],{"intervention":153,"totalTrials":44,"cells":157},{"EARLY_PHASE1":158,"PHASE1":160,"PHASE2":162,"PHASE3":164,"PHASE4":166,"NA":172},{"trials":159,"activeCount":8},[],{"trials":161,"activeCount":8},[],{"trials":163,"activeCount":8},[],{"trials":165,"activeCount":8},[],{"trials":167,"activeCount":8},[168],{"nctId":146,"briefTitle":147,"status":59,"phases":169,"primaryCompletion":149,"completion":149,"start":150,"enrollment":63,"conditions":170,"interventions":171},[39],[20],[133,153],{"trials":173,"activeCount":8},[],{"intervention":175,"totalTrials":44,"cells":176},"saline",{"EARLY_PHASE1":177,"PHASE1":179,"PHASE2":181,"PHASE3":183,"PHASE4":197,"NA":199},{"trials":178,"activeCount":8},[],{"trials":180,"activeCount":8},[],{"trials":182,"activeCount":8},[],{"trials":184,"activeCount":8},[185],{"nctId":186,"briefTitle":187,"status":59,"phases":188,"primaryCompletion":189,"completion":189,"start":190,"enrollment":191,"conditions":192,"interventions":195},"NCT00412035","Botox Injection for Lower Extremity Lengthening and Deformity Correction Surgery",[38],"2012-12","2007-01",125,[193,194],"Unequal Length of Limbs; Congenital","Lower Extremity Deformities, Congenital",[196,175],"Botulinum toxin A",{"trials":198,"activeCount":8},[],{"trials":200,"activeCount":8},[],{"intervention":202,"totalTrials":44,"cells":203},"Zoledronic Acid",{"EARLY_PHASE1":204,"PHASE1":206,"PHASE2":208,"PHASE3":210,"PHASE4":222,"NA":224},{"trials":205,"activeCount":8},[],{"trials":207,"activeCount":8},[],{"trials":209,"activeCount":8},[],{"trials":211,"activeCount":8},[212],{"nctId":213,"briefTitle":214,"status":59,"phases":215,"primaryCompletion":216,"completion":217,"start":218,"enrollment":108,"conditions":219,"interventions":221},"NCT00982124","An Efficacy and Safety Trial of Intravenous Zoledronic Acid in Infants Less Than One Year of Age, With Severe Osteogenesis Imperfecta",[38],"2015-09","2016-04","2007-10",[220],"Osteogenesis Imperfecta",[202],{"trials":223,"activeCount":8},[],{"trials":225,"activeCount":8},[],{"intervention":227,"totalTrials":44,"cells":228},"zolipidem",{"EARLY_PHASE1":229,"PHASE1":231,"PHASE2":233,"PHASE3":244,"PHASE4":246,"NA":248},{"trials":230,"activeCount":8},[],{"trials":232,"activeCount":8},[],{"trials":234,"activeCount":8},[235],{"nctId":236,"briefTitle":237,"status":59,"phases":238,"primaryCompletion":189,"completion":239,"start":240,"enrollment":15,"conditions":241,"interventions":242},"NCT00539110","Differential Effects of Zolpidem Versus Ramelteon in Burned Children",[37],"2013-11","2009-12",[28,14],[227,243],"ramelteon",{"trials":245,"activeCount":8},[],{"trials":247,"activeCount":8},[],{"trials":249,"activeCount":8},[],{"intervention":243,"totalTrials":44,"cells":251},{"EARLY_PHASE1":252,"PHASE1":254,"PHASE2":256,"PHASE3":262,"PHASE4":264,"NA":266},{"trials":253,"activeCount":8},[],{"trials":255,"activeCount":8},[],{"trials":257,"activeCount":8},[258],{"nctId":236,"briefTitle":237,"status":59,"phases":259,"primaryCompletion":189,"completion":239,"start":240,"enrollment":15,"conditions":260,"interventions":261},[37],[28,14],[227,243],{"trials":263,"activeCount":8},[],{"trials":265,"activeCount":8},[],{"trials":267,"activeCount":8},[],{"intervention":269,"totalTrials":44,"cells":270},"Melatonin",{"EARLY_PHASE1":271,"PHASE1":273,"PHASE2":275,"PHASE3":285,"PHASE4":287,"NA":289},{"trials":272,"activeCount":8},[],{"trials":274,"activeCount":8},[],{"trials":276,"activeCount":8},[277],{"nctId":278,"briefTitle":279,"status":104,"phases":280,"primaryCompletion":281,"completion":281,"start":282,"enrollment":15,"conditions":283,"interventions":284},"NCT01598259","Randomized Controlled Trial to Assess Efficacy of Melatonin for Children During Burn Rehabilitation",[37],"2016-06","2014-05",[14],[269],{"trials":286,"activeCount":8},[],{"trials":288,"activeCount":8},[],{"trials":290,"activeCount":8},[],{"intervention":292,"totalTrials":44,"cells":293},"dl-alpha-tocopheryl acetate",{"EARLY_PHASE1":294,"PHASE1":296,"PHASE2":309,"PHASE3":311,"PHASE4":313,"NA":315},{"trials":295,"activeCount":8},[],{"trials":297,"activeCount":8},[298],{"nctId":299,"briefTitle":300,"status":301,"phases":302,"primaryCompletion":303,"completion":304,"start":305,"enrollment":8,"conditions":306,"interventions":308},"NCT01413620","Vitamin E Supplementation in Burn Patients","WITHDRAWN",[36],"2017-08","2021-08","2011-08",[307],"Burn Injury",[292],{"trials":310,"activeCount":8},[],{"trials":312,"activeCount":8},[],{"trials":314,"activeCount":8},[],{"trials":316,"activeCount":8},[],{"intervention":318,"totalTrials":23,"cells":319},"Botulinum Toxin A",{"EARLY_PHASE1":320,"PHASE1":322,"PHASE2":324,"PHASE3":326,"PHASE4":342,"NA":344},{"trials":321,"activeCount":8},[],{"trials":323,"activeCount":8},[],{"trials":325,"activeCount":8},[],{"trials":327,"activeCount":8},[328,332],{"nctId":186,"briefTitle":187,"status":59,"phases":329,"primaryCompletion":189,"completion":189,"start":190,"enrollment":191,"conditions":330,"interventions":331},[38],[193,194],[196,175],{"nctId":333,"briefTitle":334,"status":59,"phases":335,"completion":336,"start":337,"enrollment":338,"conditions":339,"interventions":341},"NCT00261131","Efficacy and Functional Outcomes of Botulinum Toxin A Injections to Hamstrings in Flexed Knee Gait in Cerebral Palsy",[38],"2007-12","2006-03",250,[340],"Spastic Diplegic Cerebral Palsy",[318],{"trials":343,"activeCount":8},[],{"trials":345,"activeCount":8},[346],{"nctId":347,"briefTitle":348,"status":59,"phases":349,"completion":350,"start":190,"enrollment":351,"conditions":352,"interventions":353},"NCT00503620","The Effect of Botox on Children With Cerebral Palsy",[],"2009-06",11,[17],[318],{"intervention":355,"totalTrials":44,"cells":356},"Lactobacillus GG",{"EARLY_PHASE1":357,"PHASE1":359,"PHASE2":361,"PHASE3":363,"PHASE4":365,"NA":367},{"trials":358,"activeCount":8},[],{"trials":360,"activeCount":8},[],{"trials":362,"activeCount":8},[],{"trials":364,"activeCount":8},[],{"trials":366,"activeCount":8},[],{"trials":368,"activeCount":8},[369],{"nctId":370,"briefTitle":371,"status":104,"phases":372,"primaryCompletion":373,"completion":373,"start":374,"enrollment":23,"conditions":375,"interventions":376},"NCT00220519","Lactobacillus GG Supplementation During Pediatric Burn Injuries",[40],"2005-05","2004-10",[14],[355]]